Author:
Saggi Subodh,Fioretto Paola,Mauer Michael,Gruessner Rainer W. G.
Publisher
Springer International Publishing
Reference104 articles.
1. United States Renal Data System. 2019 USRDS annual data report: epidemiology of kidney disease in the United States 2019. 2020.
2. Mauer M, Friedman EA. Diabetic nephropathy. Boston: Little, Brown & Co; 1982.
3. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456–62.
4. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851–60.
5. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861–9.